Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Armata Pharmaceuticals ( (ARMP) ) just unveiled an update.
The Company recently amended its Credit and Convertible Credit Agreements, extending their maturity dates to January 2026, a move that could impact its financial strategy. Concurrently, the Company announced the departure of its Chief Medical Officer, Mina Pastagia, offering her a severance package as they finalize her separation terms. These developments highlight significant operational and financial shifts for the Company.
Learn more about ARMP stock on TipRanks’ Stock Analysis page.
